In contrast, in more advanced analyses, CA-125 showed a sensitivity of 95.3% and specificity of 99.4% in the diagnosis of ovarian cancer, highlighting its high clinical utility [60]. This evidence concerns the gene MUC16 and ovarian carcinoma.